Fahad Alhawday

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 5

Top Topics

Molecular Docking

Cardiovascular Disease

Top Venues

Molecules (Basel, Switzerland)

Pharmaceuticals (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Fahad Alhawday, Fahad M Alminderej, Siwar Ghannay, Bechir Hammami, Abuzar E A E Albadri, Adel Kadri, Kaiss Aouadi
In Silico Design, Synthesis, and Evaluation of Novel Enantiopure Isoxazolidines as Promising Dual Inhibitors of α-Amylase and α-Glucosidase. Molecules (Basel, Switzerland) 29 (2) (2024)
Fahad Alhawday, Fahad M Alminderej, Siwar Ghannay, Bechir Hammami, Abuzar E A E Albadri, Adel Kadri, Kaiss Aouadi
In Silico Design, Synthesis, and Evaluation of Novel Enantiopure Isoxazolidines as Promising Dual Inhibitors of α-Amylase and α-Glucosidase. Molecules (Basel, Switzerland) 29 (2) (2024)
Fahad Alhawday, Fahad M Alminderej, Siwar Ghannay, Bechir Hammami, Abuzar E A E Albadri, Adel Kadri, Kaiss Aouadi
In Silico Design, Synthesis, and Evaluation of Novel Enantiopure Isoxazolidines as Promising Dual Inhibitors of α-Amylase and α-Glucosidase. Molecules (Basel, Switzerland) 29 (2) (2024)
Fahad Alhawday, Fahad M Alminderej, Siwar Ghannay, Bechir Hammami, Abuzar E A E Albadri, Adel Kadri, Kaiss Aouadi
In Silico Design, Synthesis, and Evaluation of Novel Enantiopure Isoxazolidines as Promising Dual Inhibitors of α-Amylase and α-Glucosidase. Molecules (Basel, Switzerland) 29 (2) (2024)
Fahad Alminderej, Siwar Ghannay, Mohamed Omer Elsamani, Fahad Alhawday, Abuzar E A E Albadri, Serag Eldin I Elbehairi, Mohammad Y Alfaifi, Adel Kadri, Kaïss Aouadi
In Vitro and In Silico Evaluation of Antiproliferative Activity of New Isoxazolidine Derivatives Targeting EGFR: Design, Synthesis, Cell Cycle Analysis, and Apoptotic Inducers. Pharmaceuticals (Basel, Switzerland) 16 (7) (2023)